125 related articles for article (PubMed ID: 27303300)
21. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.
Arimura A
Jpn J Physiol; 1998 Oct; 48(5):301-31. PubMed ID: 9852340
[TBL] [Abstract][Full Text] [Related]
22. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG; Malendowicz LK
Peptides; 1998; 19(8):1443-67. PubMed ID: 9809661
[TBL] [Abstract][Full Text] [Related]
23. PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression.
Maugeri G; D'Amico AG; Reitano R; Magro G; Cavallaro S; Salomone S; D'Agata V
Front Pharmacol; 2016; 7():139. PubMed ID: 27303300
[TBL] [Abstract][Full Text] [Related]
24. Modulatory role of PACAP and VIP on HIFs expression in lung adenocarcinoma.
D'Amico AG; Maugeri G; Rasà DM; Reitano R; Saccone S; Federico C; Magro G; D'Agata V
Peptides; 2021 Dec; 146():170672. PubMed ID: 34627957
[TBL] [Abstract][Full Text] [Related]
25. PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia.
Maugeri G; D'Amico AG; Rasà DM; Saccone S; Federico C; Cavallaro S; D'Agata V
Neuropeptides; 2018 Jun; 69():84-91. PubMed ID: 29699729
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
27. PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP.
Bensalma S; Turpault S; Balandre AC; De Boisvilliers M; Gaillard A; Chadéneau C; Muller JM
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669581
[TBL] [Abstract][Full Text] [Related]
28. Parkin modulates expression of HIF-1α and HIF-3α during hypoxia in gliobastoma-derived cell lines in vitro.
Maugeri G; D'Amico AG; Reitano R; Saccone S; Federico C; Cavallaro S; D'Agata V
Cell Tissue Res; 2016 Jun; 364(3):465-474. PubMed ID: 26742768
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of parkin isoforms in human gliomas.
Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptides of the VIP family inhibit glioblastoma cell invasion.
Cochaud S; Meunier AC; Monvoisin A; Bensalma S; Muller JM; Chadéneau C
J Neurooncol; 2015 Mar; 122(1):63-73. PubMed ID: 25563813
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review).
Tang B; Yong X; Xie R; Li QW; Yang SM
Int J Oncol; 2014 Apr; 44(4):1023-31. PubMed ID: 24481544
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional signaling pathways inversely regulated in Alzheimer's disease and glioblastoma multiform.
Liu T; Ren D; Zhu X; Yin Z; Jin G; Zhao Z; Robinson D; Li X; Wong K; Cui K; Zhao H; Wong ST
Sci Rep; 2013 Dec; 3():3467. PubMed ID: 24322672
[TBL] [Abstract][Full Text] [Related]
33. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
[TBL] [Abstract][Full Text] [Related]
34. Antiproliferative effects of PACAP and VIP in serum-starved glioma cells.
D'Amico AG; Scuderi S; Saccone S; Castorina A; Drago F; D'Agata V
J Mol Neurosci; 2013 Oct; 51(2):503-13. PubMed ID: 23900722
[TBL] [Abstract][Full Text] [Related]
35. VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.
Waschek JA
Br J Pharmacol; 2013 Jun; 169(3):512-23. PubMed ID: 23517078
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
